HIV prevention among injection drug users in Kenya and Tanzania

Overall growth in numbers of new HIV infections has slowed in most regions of the world. One outlier to this improving trend, however, is the continued growth in numbers of HIV infections linked to injection drug use, especially in Eastern Europe, Central Asia, and, more recently, in sub-Saharan Africa.

This East African assessment is the initial phase of a larger CSIS project examining IDU-related HIV/AIDS issues in a number of regions. That project and this current report examine the gaps and barriers in the use of evidence-based IDU interventions in Kenya and Tanzania.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.